89 related articles for article (PubMed ID: 24815387)
1. Expression of ankyrin repeat and SOCS box containing 4 (ASB4) confers migration and invasion properties of hepatocellular carcinoma cells.
Au V; Tsang FH; Man K; Fan ST; Poon RT; Lee NP
Biosci Trends; 2014 Apr; 8(2):101-10. PubMed ID: 24815387
[TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA MALAT1 Regulates Hepatocellular Carcinoma Growth Under Hypoxia via Sponging MicroRNA-200a.
Zhao ZB; Chen F; Bai XF
Yonsei Med J; 2019 Aug; 60(8):727-734. PubMed ID: 31347327
[TBL] [Abstract][Full Text] [Related]
3. ASB4 is a hydroxylation substrate of FIH and promotes vascular differentiation via an oxygen-dependent mechanism.
Ferguson JE; Wu Y; Smith K; Charles P; Powers K; Wang H; Patterson C
Mol Cell Biol; 2007 Sep; 27(18):6407-19. PubMed ID: 17636018
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2.
Wu Q; Guo R; Lin M; Zhou B; Wang Y
Gynecol Oncol; 2011 Jul; 122(1):149-54. PubMed ID: 21529905
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma.
Ding W; Tan H; Li X; Zhang Y; Fang F; Tian Y; Li J; Pan X
Cancer Biomark; 2018; 22(3):427-434. PubMed ID: 29758928
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
Quan H; Li B; Yang J
Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
[TBL] [Abstract][Full Text] [Related]
7. The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma.
Yuan JH; Yang F; Chen BF; Lu Z; Huo XS; Zhou WP; Wang F; Sun SH
Hepatology; 2011 Dec; 54(6):2025-35. PubMed ID: 21837748
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin ligase ASB4 promotes trophoblast differentiation through the degradation of ID2.
Townley-Tilson WH; Wu Y; Ferguson JE; Patterson C
PLoS One; 2014; 9(2):e89451. PubMed ID: 24586788
[TBL] [Abstract][Full Text] [Related]
9. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W
BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250
[TBL] [Abstract][Full Text] [Related]
10. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
Li D; Zhang Y; Zhang H; Zhan C; Li X; Ba T; Qiu Z; E F; Lv G; Zou C; Wang C; Si L; Zou C; Li Q; Gao X
J Exp Clin Cancer Res; 2018 Mar; 37(1):46. PubMed ID: 29506532
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-200a inhibits epithelial-mesenchymal transition in human hepatocellular carcinoma cell line.
Zhong C; Li MY; Chen ZY; Cheng HK; Hu ML; Ruan YL; Guo RP
Int J Clin Exp Pathol; 2015; 8(9):9922-31. PubMed ID: 26617701
[TBL] [Abstract][Full Text] [Related]
12. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
Qiu G; Lin Y; Zhang H; Wu D
Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
[TBL] [Abstract][Full Text] [Related]
13. miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma.
Shyu YC; Lee TL; Lu MJ; Chen JR; Chien RN; Chen HY; Lin JF; Tsou AP; Chen YH; Hsieh CW; Huang TS
J Transl Med; 2016 Jul; 14(1):200. PubMed ID: 27370270
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-200a inhibits cell growth and metastasis by targeting Foxa2 in hepatocellular carcinoma.
Chen SY; Ma DN; Chen QD; Zhang JJ; Tian YR; Wang ZC; Cai H; Lin Y; Sun HC
J Cancer; 2017; 8(4):617-625. PubMed ID: 28367241
[No Abstract] [Full Text] [Related]
15. MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53.
Chen L; Luo L; Chen W; Xu HX; Chen F; Chen LZ; Zeng WT; Chen JS; Huang XH
Biomed Pharmacother; 2016 Dec; 84():1113-1118. PubMed ID: 27780140
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-200a and -200b mediated hepatocellular carcinoma cell migration through the epithelial to mesenchymal transition markers.
Hung CS; Liu HH; Liu JJ; Yeh CT; Chang TC; Wu CH; Ho YS; Wei PL; Chang YJ
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S360-8. PubMed ID: 22868917
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
[TBL] [Abstract][Full Text] [Related]
19. Astemizole promotes the anti-tumor effect of vitamin D through inhibiting miR-125a-5p-meidated regulation of VDR in HCC.
Xu J; Wang Y; Zhang Y; Dang S; He S
Biomed Pharmacother; 2018 Nov; 107():1682-1691. PubMed ID: 30257386
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]